PMI-06

N/A

Report date: 2025/11/20 16:02:27

NME

Base Information

Drug NamePMI-06

Drug Alias NamePMI-06PMI0618F-DK222[18F]DK-222

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPrecision Molecular Inc

China Registration ClassN/A

Develop Information

Active CompaniesPrecision Molecular Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A